Janus Henderson Group’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$55.4M Sell
912,926
-60,148
-6% -$3.51M 0.03% 389
2025
Q4
$52.5M Buy
973,074
+1,855
+0.2% +$89.2K 0.02% 406
2025
Q3
$43.8M Sell
971,219
-800
-0.1% -$37.4K 0.02% 440
2025
Q2
$45M Sell
972,019
-210,580
-18% -$10.3M 0.02% 412
2025
Q1
$71M Sell
1,182,599
-1,192,994
-50% -$69.5M 0.04% 314
2024
Q4
$134M Sell
2,375,593
-1,179,165
-33% -$65.9M 0.07% 243
2024
Q3
$184M Buy
3,554,758
+3,107,672
+695% +$146M 0.09% 196
2024
Q2
$18.6M Sell
447,086
-8,446
-2% -$378K 0.01% 586
2024
Q1
$24.7M Sell
455,532
-29,272
-6% -$1.49M 0.01% 528
2023
Q4
$24.9M Sell
484,804
-52,839
-10% -$2.77M 0.01% 503
2023
Q3
$31.2M Sell
537,643
-2,462,047
-82% -$151M 0.02% 453
2023
Q2
$192M Sell
2,999,690
-649,305
-18% -$43.5M 0.12% 173
2023
Q1
$253M Sell
3,648,995
-2,411,228
-40% -$170M 0.17% 144
2022
Q4
$436M Sell
6,060,223
-8,740,205
-59% -$659M 0.31% 80
2022
Q3
$1.05B Buy
14,800,428
+8,041,869
+119% +$583M 0.39% 56
2022
Q2
$521M Sell
6,758,559
-2,515,628
-27% -$192M 0.36% 63
2022
Q1
$677M Buy
9,274,187
+446,157
+5% +$30M 0.33% 69
2021
Q4
$550M Sell
8,828,030
-75,625
-0.8% -$4.44M 0.23% 105
2021
Q3
$527M Buy
8,903,655
+18,927
+0.2% +$1.25M 0.23% 104
2021
Q2
$594M Sell
8,884,728
-6,804,513
-43% -$444M 0.25% 96
2021
Q1
$990M Sell
15,689,241
-7,548,334
-32% -$470M 0.45% 43
2020
Q4
$1.44B Sell
23,237,575
-506,695
-2% -$31.2M 0.67% 22
2020
Q3
$1.43B Buy
23,744,270
+2,562,329
+12% +$154M 0.75% 21
2020
Q2
$1.25B Sell
21,181,941
-489,675
-2% -$29.3M 0.7% 21
2020
Q1
$1.21B Sell
21,671,616
-303,385
-1% -$18.5M 0.83% 15
2019
Q4
$1.41B Buy
21,975,001
+4,007,086
+22% +$229M 0.72% 16
2019
Q3
$911M Buy
17,967,915
+1,811,356
+11% +$85.1M 0.49% 36
2019
Q2
$733M Buy
16,156,559
+6,960,047
+76% +$324M 0.4% 55
2019
Q1
$439M Buy
9,196,512
+1,231,639
+15% +$61.4M 0.24% 101
2018
Q4
$414M Sell
7,964,873
-895,829
-10% -$48.1M 0.26% 94
2018
Q3
$550M Buy
8,860,702
+1,937,785
+28% +$115M 0.29% 82
2018
Q2
$383M Buy
6,922,917
+3,695,485
+115% +$200M 0.22% 125
2018
Q1
$204M Buy
3,227,432
+1,257,877
+64% +$80.9M 0.12% 211
2017
Q4
$121M Sell
1,969,555
-650,400
-25% -$40.7M 0.07% 324
2017
Q3
$167M Sell
2,619,955
-1,014,173
-28% -$59.2M 0.11% 234
2017
Q2
$202M Buy
3,634,128
+3,516,536
+2,990% +$191M 0.14% 200
2017
Q1
$6.39M Sell
117,592
-51,371
-30% -$2.82M 0.04% 325
2016
Q4
$9.88M Buy
168,963
+24,151
+17% +$1.32M 0.07% 281
2016
Q3
$7.81M Sell
144,812
-55,431
-28% -$3.56M 0.06% 297
2016
Q2
$14.7M Buy
200,243
+11,309
+6% +$799K 0.12% 210
2016
Q1
$12.1M Buy
188,934
+9,996
+6% +$630K 0.1% 234
2015
Q4
$12.3M Sell
178,938
-5,494
-3% -$363K 0.1% 230
2015
Q3
$10.9M Hold
184,432
0.1% 235
2015
Q2
$12.3M Sell
184,432
-7,291
-4% -$480K 0.1% 236
2015
Q1
$12.4M Sell
191,723
-11,661
-6% -$730K 0.1% 243
2014
Q4
$12M Hold
203,384
0.09% 260
2014
Q3
$10.4M Sell
203,384
-17,993
-8% -$899K 0.1% 194
2014
Q2
$10.7M Hold
221,377
0.1% 203
2014
Q1
$11.5M Buy
221,377
+49,531
+29% +$2.64M 0.11% 197
2013
Q4
$9.13M Buy
171,846
+85,355
+99% +$4.35M 0.09% 219
2013
Q3
$4M Sell
86,491
-348,532
-80% -$15.3M 0.04% 288
2013
Q2
$19.5M Buy
+435,023
New +$18.9M 0.23% 119

Other funds holding BMY

Janus Henderson Group's BMY Position: Q1 2026 in Review

Janus Henderson Group reduced its Bristol-Myers Squibb (BMY) stake by 6.2% in Q1 2026, selling an estimated $3.51M and leaving 912,926 shares worth $55.4M. The position accounts for 0.03% of the portfolio, ranked #389.

Janus Henderson Group first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.44B in Q4 2020. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Janus Henderson Group held 912,926 shares of Bristol-Myers Squibb worth $55.4M as of Q1 2026.
  • Janus Henderson Group sold 60,148 Bristol-Myers Squibb shares in Q1 2026, an estimated $3.51M.
  • Bristol-Myers Squibb made up 0.03% of Janus Henderson Group's portfolio in Q1 2026, its #389 holding.
  • Janus Henderson Group first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
  • Janus Henderson Group's Bristol-Myers Squibb position peaked at $1.44B in Q4 2020.
  • 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.